Virica Logo
Latest News2021-11-12T15:40:50-05:00

Virica Biotech Raises Series A Financing & Expands Operations to Support Clients’ Manufacturing of Viral Medicines

OTTAWA – October 4, 2021 – Virica Biotech Inc., a leading life science developer of solutions for scaling of viral medicines, announced today the first closing of its Series A financing. The round, led by Dynamk Capital, is expected to close with additional investors by the end of Q4-2021. The investment strengthens Virica’s already impressive growth trajectory, as it gears up to become a premier manufacturing partner for global viral medicine producers. The investment will be used to expand Virica’s operations with the opening of a new lab facility, that is part of the Ottawa Health Innovation Hub. Watch the grand [...]

October 27th, 2021|

Virica Biotech: Enabling Vaccine Development to Fight Against COVID-19

March 14, 2020—As the world deals with COVID-19, now officially deemed a pandemic, many groups are racing against the clock to develop vaccines against the novel coronavirus. The development and manufacturing of effective vaccines is a laborious and challenging task for a variety of reasons. In the pandemic situation that we and our loved ones are facing today, creating, manufacturing, testing, and delivering novel vaccines for a global population of more than 7 billion is truly a daunting challenge. As researchers and global citizens, we offer our heartfelt thanks to healthcare workers, researchers, governments, and biotechnology companies, who are [...]

November 10th, 2020|

Virica’s Founder and CEO Dr. Jean-Simon Diallo Spoke with CBC’s All in a Day, Alan Neal

Virica’s Founder and CEO Dr. Jean-Simon Diallo spoke in an interview with CBC on All in a Day with Alan Neal on fighting the current COVID-19 pandemic by speeding up the process of mass-producing vaccines. Virica’s VSE technology which was spun out of the Ottawa Hospital Research Institute aims to overcome the manufacturing challenges that exist in producing viruses.

November 10th, 2020|

Virica’s Founder and CEO Dr. Jean-Simon Diallo interviewed by CTV Ottawa Morning

Virica’s Founder and CEO Dr. Jean-Simon Diallo discusses his latest virology research at the Ottawa Hospital Research Institute, which focuses on Covid-19 and is funded by the Ontario Government, with CTV Ottawa Morning. His team is using a biosensor that detects the interaction with the virus and its receptor which will allow them to rapidly test small molecules and drugs for their ability to block the virus which is crucial not only for this pandemic, but also in the future.

November 10th, 2020|

Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization

Virica Biotech is proud to announce a critical $1 million collaborative project with Dr. Jean-Simon Diallo's Ottawa Hospital Research Institute lab that has been selected for grant financing by BioCanRx. The primary deliverable for this project is the generation of a set of regulatory assays and procedures forming a critical path that will enable the advancement of Dr. Diallo’s proprietary Viral Sensitizer formulation that enhances LV production for use by both academic institutes as well as large scale producers such as the BMC, one of BioCanRx’s core facilities which is manufacturing LV for ongoing Canadian CAR T.  Read this [...]

November 10th, 2020|

Virica Biotech to Participate in Two Accelerator Programs

Virica Biotech is excited to be participating in two accelerator programs: The Global US Market Expansion Accelerator – Global Soft Landing program and the Canadian Entrepreneurs in Life Sciences (CELS) program. These programs provide coaching and enable participating companies to form meaningful relationships with stakeholders, as well as establish a presence in the life sciences and technology markets in and outside of the US. Read this news article.

November 10th, 2020|

Virica Biotech Participates in BARDA Lightning Talk

BARDA selected Virica Biotech to participate in a BARDA Lightning Talk on BARDA Industry Day. Virica was proud to participate and looks forward to connecting with attendees interested in its Viral Sensitizers. Visit the website. Hear from Jean-Simon Diallo, Scientific Founder and CEO, on how our VSE Technology is enhancing manufacturing of vaccines, including hopeful COVID-19 vaccines.

November 10th, 2020|

Breakthrough technology is both intimidating and exhilarating

To achieve the promise of viral medicine, though, the innovation of many is needed. We’re here to guide the way. Let our scientific experience and expertise support you, your science and your business. Let’s talk.

Have a question? Contact Virica
Go to Top